Genworth Financial stock was last at USD 9.63 as buybacks expand

Published on 10/07/2026 at 05:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genworth Financial stock posted USD 1.901 billion in Q2 2026 revenue and USD 47 million in net income. A USD 500 million buyback expansion and USD 11.50 consensus target frame the valuation debate.

GNW, US37247D1063, Illustration mit AI erstellt.

Genworth Financial stock (ISIN US37247D1063) was last at USD 9.63 on the NYSE on October 6, 2026, at 4:00 p.m. ET, with a market capitalization of USD 3.7 billion. The price stood 9.9 percent below its 52-week high of USD 10.69, giving investors a clear measure of the stock's recent distance from its yearly peak.

Buyback expands capital returns

Genworth Financial announced a USD 500 million expansion of its existing share repurchase program on September 2, 2026. The authorization increases the role of capital returns in the investment case, while the program remains tied to holding-company cash and distributions from Enact Holdings.

The company's investor-relations materials show USD 62 million in share repurchases during Q2 2026 and USD 918 million since the program began. Enact also returned USD 103 million in capital to Genworth during the quarter, making subsidiary cash generation a central driver of the parent company's capital allocation.

Q2 revenue reaches USD 1.901 billion

For the quarter ended June 30, 2026, Genworth Financial reported USD 1.901 billion in revenue, USD 47 million in net income available to common stockholders and diluted earnings per share of USD 0.12. Adjusted operating income excluding Closed Block was USD 112 million, including USD 143 million from Enact.

The quarter also included USD 46 million in gross incremental premium approvals under the long-term-care rate action plan. Genworth said the estimated net present value achieved through those rate actions reached USD 34.8 billion as of June 30, 2026, while the legacy insurance companies reported an estimated risk-based capital ratio of 286 percent.

Analyst target remains above price

According to MarketBeat on September 16, 2026, Keefe, Bruyette and Woods lowered its price target from USD 12.00 to USD 11.50 while maintaining an Outperform rating. The consensus was Moderate Buy across three analysts with an average target of USD 11.50, which lies 19.4 percent above the October 6 price.

The counter-factor is the legacy insurance portfolio. Business Wire reported on September 17, 2026, that AM Best cited volatility in long-term-care results, rising claims costs and dependence on Enact dividends as factors in its ratings assessment.

Stock stays below yearly high

Genworth Financial stock was last at USD 9.63 on the NYSE on October 6, 2026, against a 52-week range of USD 7.84 to USD 10.69. The USD 3.7 billion market capitalization places the buyback, Q2 earnings and Enact cash distributions at the center of the valuation discussion.